Columbia Laboratories (CBRX) was renamed Juniper Pharmaceuticals (JNP) a month ago with a new focus on women’s health; this is the 1Q15 PR: http://finance.yahoo.com/news/juniper-pharmaceuticals-reports-first-quarter-110000195.html The flagship product candidate is a segmented* intra-vaginal ring co-developed by Robert Langer, who is well known to most readers of this board. *I.e. capable of delivering multiple drugs simultaneously.